Of Counsel
Jenevieve's practice spans a broad range of industries, including pharmaceuticals, medical devices, education, technology, food, fashion, financial services, and consumer products. World Trademark Review notes that Jenevieve is a "valuable contact . . . particularly for pharmaceutical companies, thanks to her sophisticated understanding of the branding issues they face." She represents companies at every stage of development, from innovative startups to established multinational corporations with global trademark portfolios.
In addition to trademark strategy, Jenevieve counsels clients on copyright, social media, right of publicity, false advertising, and related issues. Drawing on her professional background in book publishing, she advises creators, publishers, and users of copyright-protected content on publishing, licensing, and registration matters.
When disputes arise, Jenevieve brings strong advocacy skills and pragmatic tactical thinking to enforcement matters on behalf of both plaintiffs and defendants. She has experience litigating trademark, trade dress, and copyright infringement and ownership disputes in federal court, and she regularly handles opposition and cancellation proceedings before the U. S. Trademark Trial and Appeal Board (TTAB) of the U.S. Patent and Trademark Office (USPTO).
In addition to repeated recognition and for her contributions to the fields of prosecution and strategy in World Trademark Review's WTR 1000- The World's Leading Trademark Professionals, Jenevieve has been recognized as an "Up & Coming Lawyer" by Massachusetts Lawyers Weekly.
Prior to joining Finnegan, Jenevieve co-chaired the trademark, copyright, and unfair competition group at a general practice firm and served as a judicial law clerk for the Honorable Margot Botsford of the Massachusetts Supreme Judicial Court. Before studying law, Jenevieve spent several years in the editorial acquisitions and licensing department of an academic book publisher, where she was responsible for author contracts, permissions, and copyright issues.
Event
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
INCONTESTABLE® Blog
Lack of FDA Approval for Uncle Bud Means No Bona Fide Intent to Use Medical CBD Goods in Legal Commerce Lack of FDA Approval for Uncle Bud Means No Bona Fide Intent to Use Medical CBD Goods in Legal Commerce
April 19, 2024
INCONTESTABLE® Blog
A Tale of Widows and (Sparkling) Wine: TTAB Cancels VEUVE OLIVIER Registration for Likelihood of Confusion with VEUVE CLICQUOT A Tale of Widows and (Sparkling) Wine: TTAB Cancels VEUVE OLIVIER Registration for Likelihood of Confusion with VEUVE CLICQUOT
April 12, 2024
INCONTESTABLE® Blog
Fifth Circuit Finds Speculation and Clichés Not Enough to Make Musician Plaintiff a Copyright Rockstar Fifth Circuit Finds Speculation and Clichés Not Enough to Make Musician Plaintiff a Copyright Rockstar
April 4, 2024
INCONTESTABLE® Blog
Winning the Battle but Not the War: Disclaimer Requirement Overturned, Section 2(d) Objection Upheld Winning the Battle but Not the War: Disclaimer Requirement Overturned, Section 2(d) Objection Upheld
March 28, 2024
Articles
A Rainbow of Lessons from Fruity Pebbles' TTAB Loss A Rainbow of Lessons from Fruity Pebbles' TTAB Loss
March 22, 2024
Law360Award/Ranking
Finnegan Tops the 2024 World Trademark Review 1000, Receiving New Regional Accolade Finnegan Tops the 2024 World Trademark Review 1000, Receiving New Regional Accolade
February 13, 2024
World Trademark ReviewDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.